ABC:NYE-AmerisourceBergen Corporation (USD)

COMMON STOCK | Medical Distribution | NYE

Last Closing Price

USD 132.39

Change

-1.42 (-1.06)%

Market Cap

USD 28.35B

Volume

0.89M

Avg Analyst Target

USD 146.75 (+10.85%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


AmerisourceBergen Corporation (ABC) Stock Analysis:
Based on the AmerisourceBergen Corporation stock forecasts from 6 analysts, the average analyst target price for AmerisourceBergen Corporation is USD 146.75 over the next 12 months. AmerisourceBergen Corporation’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of AmerisourceBergen Corporation is Bullish , which is based on 11 positive signals and 3 negative signals. At the last closing, AmerisourceBergen Corporation’s stock price was USD 132.39. AmerisourceBergen Corporation’s stock price has changed by -3.32% over the past week, +7.21% over the past month and +27.56% over the last year.

About

AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and e ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-01-19 )

Largest Industry Peers for Medical Distribution

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
MCK McKesson Corporation

-1.39 (-0.55%)

USD38.35B 36.39 8.79
CAH Cardinal Health Inc

-0.52 (-0.99%)

USD14.96B 13.70 7.41
OMI Owens & Minor Inc

+1.35 (+3.07%)

USD3.34B 14.26 9.45
PBH Prestige Consumer Healthcare I..

+0.15 (+0.26%)

USD2.92B 16.47 13.45
7459 Medipal Holdings Corp

N/A

N/A N/A N/A

ETFs Containing ABC

Symbol Name Weight Mer Price(Change) Market Cap
FLUD Franklin Liberty Ultra Sh.. 4.03 % 0.15 %

+0.01 (+0.02%)

N/A
CHEP AGFiQ U.S. Market Neutral.. 0.00 % 1.42 %

N/A

USD0.75M
ESGF Invesco Global ESG Revenu.. 0.00 % 0.45 %

N/A

USD0.02B
FHC:CA First Trust Dow Jones Int.. 0.00 % 0.77 %

N/A

USD4.88M
FLAG First Light Acquisition G.. 0.00 % 1.44 %

N/A

USD0.28B
WBIF Absolute Shares Trust - W.. 0.00 % 1.25 %

-0.42 (-1.35%)

USD0.05B
WBIG WBI BullBear Yield 3000 E.. 0.00 % 1.14 %

-0.46 (-1.66%)

USD0.04B
FHC-F:CA First Trust Dow Jones Int.. 0.00 % 0.00 %

N/A

N/A
GBLO Global Beta Low Beta ETF 0.00 % 0.29 %

-0.03 (-0.12%)

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Distribution)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.38% 40% F 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.38% 40% F 64% D
Trailing 12 Months  
Capital Gain 27.56% 40% F 83% B
Dividend Return 1.72% 75% C 33% F
Total Return 29.27% 40% F 82% B-
Trailing 5 Years  
Capital Gain 58.08% 80% B- 70% C-
Dividend Return 9.67% 75% C 34% F
Total Return 67.74% 80% B- 68% D+
Average Annual (5 Year Horizon)  
Capital Gain 9.09% 60% D- 58% F
Dividend Return 1.84% 75% C 44% F
Total Return 10.94% 80% B- 57% F
Risk Return Profile  
Volatility (Standard Deviation) 14.48% 100% A+ 72% C-
Risk Adjusted Return 75.51% 100% A+ 79% C+
Market Capitalization 28.35B 80% B- 90% A-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Distribution)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 16.11 60% D- 55% F
Price/Book Ratio 114.74 20% F 1% F
Price / Cash Flow Ratio 37.56 20% F 9% F
EV/EBITDA 10.20 40% F 59% F
Management Effectiveness  
Return on Equity -9,999,999.00% 20% F 5% F
Return on Invested Capital 32.35% 80% B- 95% A
Return on Assets 3.29% 60% D- 57% F
Debt to Equity Ratio 1,092.33% 20% F 2% F
Technical Ratios  
Short Ratio 2.02 80% B- 49% F
Short Percent 1.35% 80% B- 69% D+
Beta 0.51 80% B- 82% B-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.